LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
LBPH on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$38,116 0
2024 Q4 0 $0 -$1,326,024,641 0
2024 Q3 39,804,356 $1,326,431,268 +$20,907,927 $33.33 121
2024 Q2 38,765,876 $1,047,844,432 +$28,399,906 $27.03 98
2024 Q1 37,941,245 $819,531,685 +$470,945,810 $21.60 105
2023 Q4 16,527,897 $99,664,586 +$5,448,370 $6.03 52
2023 Q3 15,660,152 $87,070,626 +$6,107,538 $5.56 51
2023 Q2 14,536,383 $106,710,613 +$13,632,063 $7.34 50
2023 Q1 13,190,232 $51,455,059 +$23,093,421 $4.01 25
2022 Q4 7,273,280 $23,333,765 -$71,483 $3.26 18
2022 Q3 7,260,149 $27,002,000 -$1,022,853 $3.72 16
2022 Q2 7,539,604 $23,296,000 -$323,603 $3.09 17
2022 Q1 7,614,687 $40,073,000 -$862,605 $5.21 19
2021 Q4 7,782,202 $37,755,000 +$490,947 $4.84 19
2021 Q3 7,670,623 $68,171,000 -$2,738,648 $8.87 19
2021 Q2 7,976,370 $71,686,000 -$13,476,821 $9.12 15
2021 Q1 8,903,335 $142,774,000 +$142,774,000 $16.36 22